| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/14/2009 | US20090123527 Method of inducing topical anesthesia and transdermal patch |
| 05/14/2009 | US20090123524 Packaged satiety enhancing composition |
| 05/14/2009 | US20090123523 Pharmaceutical delivery system |
| 05/14/2009 | US20090123522 Medicament Delivery Device and a Method of Medicament Delivery |
| 05/14/2009 | US20090123520 Keloid Therapy |
| 05/14/2009 | US20090123512 Quorum Sensing Modulators |
| 05/14/2009 | US20090123511 Biomaterial derived from vertebrate liver tissue |
| 05/14/2009 | US20090123510 Medical implants containing adenosine receptor agonists and methods for inhibiting medical implant loosening |
| 05/14/2009 | US20090123509 Biodegradable Colloidal Gels as Moldable Tissue Engineering Scaffolds |
| 05/14/2009 | US20090123508 Implantable Drug Depot for Intrathecal Drug Delivery System for Pain Management |
| 05/14/2009 | US20090123504 Olive oil formulation for pain relief |
| 05/14/2009 | US20090123503 Conditioned Cell Culture Medium Compositions and Methods of Use |
| 05/14/2009 | US20090123502 Multi-layered fondant containing chewing gum |
| 05/14/2009 | US20090123472 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| 05/14/2009 | US20090123453 Pharmaceutical Preparations And Medicines Capable Of Generating, And/Or Containing, Thrombin |
| 05/14/2009 | US20090123450 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
| 05/14/2009 | US20090123422 Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-y |
| 05/14/2009 | US20090123392 Fragrance accords to combat the perception of body odor |
| 05/14/2009 | US20090123391 Novel Formulations |
| 05/14/2009 | US20090123390 Compositions for the treatment of gastrointestinal inflammation |
| 05/14/2009 | US20090123389 Methods for modulating Th17 cell development in the treatment and prevention of cellulite |
| 05/14/2009 | US20090123388 Prodrugs of Short-Chain Fatty Acids and Treatment Methods |
| 05/14/2009 | US20090123387 Buccal, polar and non-polar spray or capsule containing cardiovascular or reneal drugs |
| 05/14/2009 | US20090123386 Abuse Resistant Capsules |
| 05/14/2009 | US20090123366 Targeted Therapy |
| 05/14/2009 | US20090121709 Peptide nanostructures encapsulating A foreign material and method of manufacturing same |
| 05/14/2009 | CA2705159A1 Methods for administering corticosteroid formulations |
| 05/14/2009 | CA2705153A1 Intranasal compositions |
| 05/14/2009 | CA2705063A1 Fast release solid formulation, preparation and use thereof |
| 05/14/2009 | CA2704928A1 Anesthetic composition, formulation and method of use |
| 05/14/2009 | CA2704859A1 Topical treatment with dapsone in g6pd-deficient patients |
| 05/14/2009 | CA2704778A1 Formulations for enhanced bioavailability of orally administered polar agents |
| 05/14/2009 | CA2704646A1 Sustained-release tablets with hydromorphone |
| 05/14/2009 | CA2704639A1 Dry powder formulations comprising ascorbic acid derivates |
| 05/14/2009 | CA2704474A1 Wet granulation using a water sequestering agent |
| 05/14/2009 | CA2704236A1 Nucleic acid complex and nucleic acid delivery composition |
| 05/14/2009 | CA2703872A1 Lidocaine tape preparation |
| 05/14/2009 | CA2703598A1 Dual-acting pharmaceutical compositions based on superstructures of angiotensin receptor antagonist/blocker (arb) and neutral endopeptidase (nep) inhibitor |
| 05/14/2009 | CA2703539A1 Intrauterine deposit |
| 05/14/2009 | CA2703000A1 Water-immiscible materials as vehicles for drug delivery |
| 05/13/2009 | EP2058754A1 Actuation indicator for a dispensing device |
| 05/13/2009 | EP2058516A2 Microfluidic osmotic pump |
| 05/13/2009 | EP2058329A1 Improved secretion of neublastin |
| 05/13/2009 | EP2058311A2 8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as medicine |
| 05/13/2009 | EP2058275A1 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 05/13/2009 | EP2058010A1 Pharmaceutical composition |
| 05/13/2009 | EP2058009A1 Reverse targeting lipid vesicle |
| 05/13/2009 | EP2057990A1 Lipid metabolism improving agent containing hydrogen molecule |
| 05/13/2009 | EP2057989A1 Freeze-dried preparation of 1-methylcarbapenem |
| 05/13/2009 | EP2057988A1 Nail patch |
| 05/13/2009 | EP2057987A1 Pharmaceutical composition containing statin-encapsulated nanoparticle |
| 05/13/2009 | EP2057986A1 Soft capsules based on natural polysaccharides containing polyvinyl alcohol - polyethylenglycol - plug copolymers |
| 05/13/2009 | EP2057985A1 Coated tablet |
| 05/13/2009 | EP2057984A1 Retard tablets with hydromorphon |
| 05/13/2009 | EP2057983A1 Compositions for the topical protection of the ocular tissues from the damaging effects of ultraviolet radiations |
| 05/13/2009 | EP2057982A1 Intranasal compositions |
| 05/13/2009 | EP2057972A1 Intrauterine deposit |
| 05/13/2009 | EP2057265A2 Compositions for reducing cell adhesion to bubbles |
| 05/13/2009 | EP2056922A2 In-dwelling port for access into a body |
| 05/13/2009 | EP2056902A1 Drug delivery device with piezoelectric actuator |
| 05/13/2009 | EP2056883A2 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
| 05/13/2009 | EP2056878A2 Conducting polymer nanotube actuators for precisely controlled release of medicine and bioactive molecules |
| 05/13/2009 | EP2056873A2 Methods and compositions for needleless delivery of particles |
| 05/13/2009 | EP2056866A2 Use of a botulinum toxin for treating a urethral stricture |
| 05/13/2009 | EP2056862A2 Parathyroid hormone analogues and uses thereof |
| 05/13/2009 | EP2056848A2 Use of extracts for the treatment of viral disorders |
| 05/13/2009 | EP2056835A2 Pharmaceutical compositions and uses thereof |
| 05/13/2009 | EP2056832A1 Compositions, suitable for oral administration, comprising a triazolo [4, 5-d]pyrimidin derivate |
| 05/13/2009 | EP2056809A1 Ophthalmic percutaneous absorption type preparation |
| 05/13/2009 | EP2056798A2 Sorbic acid analog co-crystals |
| 05/13/2009 | EP2056797A2 Controlled release system and method for manufacturing the same |
| 05/13/2009 | EP2056796A2 Lyophilized preparation |
| 05/13/2009 | EP2056795A2 Process for preparing pramipexole dihydrochloride tablets with high storage stability |
| 05/13/2009 | EP2056794A2 Multistage delivery of active agents |
| 05/13/2009 | EP2056793A2 Free base gacyclidine nanoparticles |
| 05/13/2009 | EP2056792A2 Drug delivery systems comprising solid solutions of weakly basic drugs |
| 05/13/2009 | EP2056791A2 Pharmaceutical compositions including vitamin d and corticosteroid |
| 05/13/2009 | EP2056790A2 Galenic formulations of aliskiren |
| 05/13/2009 | EP2056779A2 Use of a composition for skin treatment during x-ray irradiation |
| 05/13/2009 | EP2056672A2 Patch for the expulsion of insect poison from the skin after stings from membranous insects (hymenoptera) |
| 05/13/2009 | EP1965768B1 Fexofenadine suspension formulation |
| 05/13/2009 | EP1965765B1 COMPOSITION CONTAINING A SIO2-NANOPARTICLE LIPOSOMAL DISPERSION AND AN ß-1,3-LINKED GLUCAN-ETHER DERIVATIVE |
| 05/13/2009 | EP1843749B1 Controlled release compositions for interferon based on pegt/pbt block copolymers |
| 05/13/2009 | EP1753434B1 Enhanced bimatoprost ophthalmic solution |
| 05/13/2009 | EP1648471A4 Methods for the treatment of male and female sexual dysfunction |
| 05/13/2009 | EP1617816B1 Nanoparticulate meloxican formulations |
| 05/13/2009 | EP1556013B1 Deferasirox dispersible tablets |
| 05/13/2009 | EP1429770B1 New formulations and use thereof |
| 05/13/2009 | EP1363538A4 Enhanced ultrasound detection with temperature dependent contrast agents |
| 05/13/2009 | EP1327440B1 Oral preparations with favorable disintegration characteristics |
| 05/13/2009 | EP1318786B1 Use of an outer backing layer for the manufacture of an implantable drug delivery patch |
| 05/13/2009 | EP1299104B1 Tamper-resistant oral opioid agonist formulations |
| 05/13/2009 | EP1237703B1 Method for producing solid shapes containing an active ingredient |
| 05/13/2009 | EP1232252B1 Reversibly inactivated acidified plasmin |
| 05/13/2009 | EP1178818A4 A stable composition comprising epidermal growth factor as an active ingredient |
| 05/13/2009 | CN101432383A Nonaqueous pressure-sensitive adhesive composition, patches and process for production of patches |
| 05/13/2009 | CN101432333A Water dispersible films for delivery of active agents to the epidermis |
| 05/13/2009 | CN101432256A Method for stabilization of reduced coenzyme Q10 |
| 05/13/2009 | CN101432032A Osmotic pump with at least one chargeable material |
| 05/13/2009 | CN101432021A Composition comprising an antigen-recognizing molecule and a lipid-based carrier |